Yu Wang

Dr. Yu Wang

University of Pennsylvania, School of Dental Medicine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MMMatthen Mathew
Matthen Mathew
MZMariam Zade
Mariam Zade
NMNadia Mezghani
Nadia Mezghani
RPRomil Patel
Romil Patel
YWYu Wang
Yu Wang
FMFatemeh Momen-Heravi
Fatemeh Momen-Heravi
Extracellular vesicles (EVs), including exosomes and microvesicles, are membrane-bound vesicles secreted by most cell types during both physiologic conditions as well in response to cellular stress. EVs play an important role in intercellular communication and are emerging as key players in tumor immunology. Tumor-derived EVs (TDEs) harbor a diverse array of tumor neoantigens and contain unique molecular signature that is reflective of tumor’s underlying genetic complexity. As such they offer a glimpse into the immune tumor microenvironment (TME) and have the potential to be a novel, minimally invasive biomarker for cancer immunotherapy. Immune checkpoint inhibitors (ICI), such as anti- programmed death-1(PD-1) and its ligand (PD-L1) antibodies, have revolutionized the treatment of a wide variety of solid tumors including head and neck squamous cell carcinoma, urothelial carcinoma, melanoma, non-small cell lung cancer, and others. Typically, an invasive tissue biopsy is required both for histologic diagnosis and next-generation sequencing efforts; the latter have become more widespread in daily clinical practice. There is an unmet need for noninvasive or minimally invasive (e.g., plasma-based) biomarkers both for diagnosis and treatment monitoring. Targeted analysis of EVs in biospecimens, such as plasma and saliva could serve this purpose by potentially obviating the need for tissue sample. In this review, we describe the current challenges of biomarkers in cancer immunotherapy as well as the mechanistic role of TDEs in modulating antitumor immune response.

1 December 2014 in Stem Cell Reports
Verified
Journal Article
Open access
SLShih-Pei Lin
Shih-Pei Lin
FCFang-Yao Chiu
Fang-Yao Chiu
YWYu Wang
Yu Wang
MYMen-Luh Yen
Men-Luh Yen
SKShou-Yen Kao
Shou-Yen Kao
SHShih-Chieh Hung
Shih-Chieh Hung
Many cell therapies currently being tested are based on mesenchymal stromal cells (MSCs). However, MSCs start to enter the senescent state upon long-term expansion. The role of retinoblastoma (RB) protein in regulating MSC properties is not well studied. Here, we show that RB levels are higher in early-passage MSCs compared with late-passage MSCs. RB knockdown induces premature senescence and reduced differentiation potentials in early-passage MSCs. RB overexpression inhibits senescence and increases differentiation potentials in late-passage MSCs. Expression of DNMT1, but not DNMT3A or DNMT3B, is also higher in early-passage MSCs than in late-passage MSCs. Furthermore, DNMT1 knockdown in early-passage MSCs induces senescence and reduces differentiation potentials, whereas DNMT1 overexpression in late-passage MSCs has the opposite effect. These results demonstrate that RB expressed in early-passage MSCs upregulates DNMT1 expression and inhibits senescence in MSCs. Therefore, genetic modification of RB could be a way to improve the efficiency of MSCs in clinical use.

1 June 2020 in Journal of Endodontics
Verified
Journal Article
Closed access
SLSu-Min Lee
Su-Min Lee
YYYa-Hsin Yu
Ya-Hsin Yu
YWYu Wang
Yu Wang
EKEuiseong Kim
Euiseong Kim
SKSyngcuk Kim
Syngcuk Kim

3 December 2019 in Current Oral Health Reports
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
PSPanagiota G. Stathopoulou
Panagiota G. Stathopoulou

26 November 2019 in Dental Materials Journal
Verified
Journal Article
Open access
PDF file
JKJustin Kang
Justin Kang
NINaomi Izutani
Naomi Izutani
MDMarina D’angelo
Marina D’angelo
WBWilliam Buis
William Buis
YWYu Wang
Yu Wang
Fusun OzerFusun Ozer
Fusun Ozer
Endogenous dentinal matrix metalloproteinases (MMPs) have been implicated in the auto-degradation of collagen fibrils within resin infiltrated layers of dentinal attachment. In order to target these proteinases, we must know which MMPs are produced and activated at the resin/dentin interface. In this study, we have optimized an extraction procedure and quantitated levels of endogenous MMPs in samples of dentin removed from the cavity walls of a single, extracted tooth. In our tooth-cavity model, an occlusal cavity (2×4×2 mm) was prepared and removed from the tooth crown, leaving surrounding dentinal walls of 1-mm-thick. The samples were pulverized with an analytic mill. Using enzyme-linked immunosorbent assay (ELISA), an average of 34.7 picograms of MMP-9 was detected in less than 300 mg of dentinal powder. This is the first study of its kind to quantitate endogenous levels of MMP in dentinal protein isolated from the cavity walls of a single, extracted tooth.